{"id":"https://openalex.org/W2066680949","doi":"https://doi.org/10.1158/1535-7163.mct-14-0258","title":"BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD","display_name":"BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD","alternate_titles":[],"publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W2066680949","doi":"https://doi.org/10.1158/1535-7163.mct-14-0258","mag":"2066680949","pmid":"https://pubmed.ncbi.nlm.nih.gov/25053825","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4185220"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-14-0258","doi":"https://doi.org/10.1158/1535-7163.mct-14-0258","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0258","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2066680949"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4185220/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067678169","display_name":"Warren C. Fiskus","orcid":"https://orcid.org/0000-0002-7343-6214","observed_orcids":["https://orcid.org/0000-0002-7343-6214"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Warren Fiskus","raw_affiliation_strings":["1Baylor College of Medicine, Houston, Texas","Baylor College of Medicine , Houston , Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Baylor College of Medicine, Houston, Texas","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Baylor College of Medicine , Houston , Texas","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108551216","display_name":"Sunil Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sunil Sharma","raw_affiliation_strings":["2University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072926885","display_name":"Jun Qi","orcid":"https://orcid.org/0000-0002-1461-3356","observed_orcids":["https://orcid.org/0000-0002-1461-3356"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jun Qi","raw_affiliation_strings":["3Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111510250","display_name":"Bhavin Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286254","display_name":"Houston Methodist Research Institute","ror":"https://ror.org/01mcrxx35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1295876152","https://openalex.org/I4405286254"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bhavin Shah","raw_affiliation_strings":["4Houston Methodist Research Institute, Houston, Texas","HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Houston Methodist Research Institute, Houston, Texas","institution_ids":["https://openalex.org/I4405286254"]},{"raw_affiliation_string":"HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS","institution_ids":["https://openalex.org/I4405286254"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055171890","display_name":"Santhana G.T. Devaraj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286254","display_name":"Houston Methodist Research Institute","ror":"https://ror.org/01mcrxx35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1295876152","https://openalex.org/I4405286254"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Santhana G.T. Devaraj","raw_affiliation_strings":["4Houston Methodist Research Institute, Houston, Texas","HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Houston Methodist Research Institute, Houston, Texas","institution_ids":["https://openalex.org/I4405286254"]},{"raw_affiliation_string":"HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS","institution_ids":["https://openalex.org/I4405286254"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091446214","display_name":"Christopher M. Leveque","orcid":"https://orcid.org/0000-0002-7391-6568","observed_orcids":["https://orcid.org/0000-0002-7391-6568"]},"institutions":[{"id":"https://openalex.org/I4405286254","display_name":"Houston Methodist Research Institute","ror":"https://ror.org/01mcrxx35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1295876152","https://openalex.org/I4405286254"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher Leveque","raw_affiliation_strings":["4Houston Methodist Research Institute, Houston, Texas","HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Houston Methodist Research Institute, Houston, Texas","institution_ids":["https://openalex.org/I4405286254"]},{"raw_affiliation_string":"HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS","institution_ids":["https://openalex.org/I4405286254"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021235748","display_name":"Bryce Patrick Portier","orcid":"https://orcid.org/0000-0002-4479-221X","observed_orcids":["https://orcid.org/0000-0002-4479-221X"]},"institutions":[{"id":"https://openalex.org/I4405286254","display_name":"Houston Methodist Research Institute","ror":"https://ror.org/01mcrxx35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1295876152","https://openalex.org/I4405286254"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bryce P. Portier","raw_affiliation_strings":["4Houston Methodist Research Institute, Houston, Texas","HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Houston Methodist Research Institute, Houston, Texas","institution_ids":["https://openalex.org/I4405286254"]},{"raw_affiliation_string":"HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS","institution_ids":["https://openalex.org/I4405286254"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027071793","display_name":"Swaminathan P. Iyer","orcid":"https://orcid.org/0000-0002-1646-813X","observed_orcids":["https://orcid.org/0000-0002-1646-813X"]},"institutions":[{"id":"https://openalex.org/I4405286254","display_name":"Houston Methodist Research Institute","ror":"https://ror.org/01mcrxx35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1295876152","https://openalex.org/I4405286254"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Swaminathan Iyer","raw_affiliation_strings":["4Houston Methodist Research Institute, Houston, Texas","HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Houston Methodist Research Institute, Houston, Texas","institution_ids":["https://openalex.org/I4405286254"]},{"raw_affiliation_string":"HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS","institution_ids":["https://openalex.org/I4405286254"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110274677","display_name":"James E. Bradner","orcid":"https://orcid.org/0000-0002-2718-4415","observed_orcids":["https://orcid.org/0000-0002-2718-4415","https://orcid.org/0000-0003-1422-5318"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James E. Bradner","raw_affiliation_strings":["3Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079069209","display_name":"Kapil N. Bhalla","orcid":"https://orcid.org/0000-0001-5209-5126","observed_orcids":["https://orcid.org/0000-0001-5209-5126"]},"institutions":[{"id":"https://openalex.org/I4405286254","display_name":"Houston Methodist Research Institute","ror":"https://ror.org/01mcrxx35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1295876152","https://openalex.org/I4405286254"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kapil N. Bhalla","raw_affiliation_strings":["4Houston Methodist Research Institute, Houston, Texas","HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Houston Methodist Research Institute, Houston, Texas","institution_ids":["https://openalex.org/I4405286254"]},{"raw_affiliation_string":"HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON, TEXAS","institution_ids":["https://openalex.org/I4405286254"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5079069209"],"corresponding_institution_ids":["https://openalex.org/I4405286254"],"apc_list":null,"apc_paid":null,"fwci":10.2781,"has_fulltext":false,"cited_by_count":145,"citation_normalized_percentile":{"value":0.98690778,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"13","issue":"10","first_page":"2315","last_page":"2327"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.057500001043081284,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.968999981880188},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.878000020980835},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9070000052452087},{"id":"https://openalex.org/keywords/ponatinib","display_name":"ponatinib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/ac220","display_name":"AC220","score":0.9769999980926514},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.8730000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5569999814033508},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7689999938011169},{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.8009999990463257},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8960000276565552},{"id":"https://openalex.org/keywords/stat5","display_name":"STAT5","score":0.49900001287460327},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.7419999837875366},{"id":"https://openalex.org/keywords/erk1-2","display_name":"ERK1/2","score":0.8029999732971191},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.7020000219345093},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9049999713897705},{"id":"https://openalex.org/keywords/cdk4-6","display_name":"CDK4/6","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mv4-11","display_name":"MV4-11","score":0.871999979019165}],"concepts":[{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.6808031797409058},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5742996335029602},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5207802653312683},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4774087965488434},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.4635784924030304},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.43326008319854736},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.43086960911750793},{"id":"https://openalex.org/C33195913","wikidata":"https://www.wikidata.org/wiki/Q20970121","display_name":"XIAP","level":5,"score":0.4270328879356384},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3839697241783142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37926971912384033},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.2929278314113617},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.21420079469680786},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.1997922956943512},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.15869706869125366},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.12265706062316895},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000092468","descriptor_name":"Bromodomain Containing Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040281","descriptor_name":"Vascular Endothelial Growth Factor Receptor-1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051941","descriptor_name":"fms-Like Tyrosine Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051941","descriptor_name":"fms-Like Tyrosine Kinase 3","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051941","descriptor_name":"fms-Like Tyrosine Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-14-0258","doi":"https://doi.org/10.1158/1535-7163.mct-14-0258","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0258","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:25053825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25053825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4185220","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4185220/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4185220","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4185220/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5264139033","display_name":"Novel Targeted Therapy for AML","funder_award_id":"R01CA171338","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5490388867","display_name":"Targeted Therapy for AML Stem Cells","funder_award_id":"R01CA173877","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1523117612","https://openalex.org/W1967269645","https://openalex.org/W1967358345","https://openalex.org/W1973537479","https://openalex.org/W1974306958","https://openalex.org/W1976033223","https://openalex.org/W1981811959","https://openalex.org/W1984209370","https://openalex.org/W1984712646","https://openalex.org/W1985522609","https://openalex.org/W1985877500","https://openalex.org/W2000596495","https://openalex.org/W2001777678","https://openalex.org/W2001799880","https://openalex.org/W2001854096","https://openalex.org/W2002395443","https://openalex.org/W2005691176","https://openalex.org/W2007351520","https://openalex.org/W2007812119","https://openalex.org/W2008001245","https://openalex.org/W2009478222","https://openalex.org/W2009949436","https://openalex.org/W2037548653","https://openalex.org/W2041535798","https://openalex.org/W2044308376","https://openalex.org/W2047790609","https://openalex.org/W2048811029","https://openalex.org/W2048964430","https://openalex.org/W2051815726","https://openalex.org/W2056465113","https://openalex.org/W2058943350","https://openalex.org/W2069849780","https://openalex.org/W2069931679","https://openalex.org/W2072898686","https://openalex.org/W2076031927","https://openalex.org/W2076333986","https://openalex.org/W2077945404","https://openalex.org/W2082117339","https://openalex.org/W2088307815","https://openalex.org/W2088947217","https://openalex.org/W2095013649","https://openalex.org/W2111815169","https://openalex.org/W2120572492","https://openalex.org/W2129129812","https://openalex.org/W2131138683","https://openalex.org/W2137465688","https://openalex.org/W2147338626","https://openalex.org/W2152981209","https://openalex.org/W2169287961","https://openalex.org/W2170419109"],"related_works":["https://openalex.org/W170639232","https://openalex.org/W1940521740","https://openalex.org/W3200363112","https://openalex.org/W4410119887","https://openalex.org/W2155331217","https://openalex.org/W2767156284","https://openalex.org/W3212564293","https://openalex.org/W2968747963","https://openalex.org/W2565849153","https://openalex.org/W3210605736"],"abstract_inverted_index":{"Recently,":[0],"treatment":[1,148],"with":[2,37,68,73,88,119,158,167,188,221,232],"bromodomain":[3],"and":[4,18,39,54,75,84,90,99,111,121,164,190,203,223,234],"extraterminal":[5],"protein":[6],"antagonist":[7],"(BA)":[8],"such":[9],"as":[10,66,102,104],"JQ1":[11,38,74,89,120,147,189],"has":[12],"been":[13],"shown":[14],"to":[15,145,177,183,240],"inhibit":[16],"growth":[17],"induce":[19,50],"apoptosis":[20,51,150,199],"of":[21,52,81,96,108,135,151,200,218],"human":[22,57,170,226],"acute":[23],"myelogenous":[24],"leukemia":[25],"(AML)":[26],"cells,":[27],"including":[28],"those":[29],"expressing":[30,63,156,229],"FLT3-ITD.":[31,64],"Here,":[32],"we":[33],"demonstrate":[34],"that":[35],"cotreatment":[36,72,87,118,187],"the":[40,76,91,94,168,191,210,214],"FLT3":[41],"tyrosine":[42],"kinase":[43],"inhibitor":[44,194],"(TKI)":[45],"ponatinib":[46],"or":[47,159,231],"AC220":[48,178],"synergistically":[49,197],"cultured":[53],"primary":[55],"CD34(+)":[56,128],"AML":[58,115,143,171,227,237],"blast":[59],"progenitor":[60,132],"cells":[61,144,154,175,228,238],"(BPC)":[62],"Concomitantly,":[65],"compared":[67],"each":[69],"agent":[70],"alone,":[71],"FLT3-TKI":[77,92,122,224],"caused":[78],"greater":[79],"attenuation":[80,107],"c-MYC,":[82],"BCL2,":[83],"CDK4/6.":[85],"Simultaneously,":[86],"increased":[93],"levels":[95,113],"p21,":[97],"BIM,":[98],"cleaved":[100],"PARP,":[101],"well":[103],"mediated":[105],"marked":[106],"p-STAT5,":[109],"p-AKT,":[110],"p-ERK1/2":[112],"in":[114,215],"BPCs.":[116],"Conversely,":[117],"was":[123],"significantly":[124],"less":[125],"active":[126],"against":[127,225,236],"normal":[129],"bone":[130],"marrow":[131],"cells.":[133,205],"Knockdown":[134],"BRD4":[136],"by":[137],"short":[138],"hairpin":[139],"RNA":[140],"also":[141],"sensitized":[142],"FLT3-TKI.":[146,241],"induced":[149,198],"mouse":[152],"Ba/F3":[153],"ectopically":[155],"FLT3-ITD":[157,230],"without":[160],"FLT3-TKI-resistant":[161,201],"mutations":[162],"F691L":[163],"D835V.":[165],"Compared":[166],"parental":[169],"FLT3-ITD-expressing":[172],"MOLM13,":[173],"MOLM13-TKIR":[174,202],"resistant":[176,239],"were":[179],"markedly":[180],"more":[181],"sensitive":[182],"JQ1-induced":[184],"apoptosis.":[185],"Furthermore,":[186],"pan-histone":[192],"deacetylase":[193],"(HDI)":[195],"panobinostat":[196],"MV4-11-TKIR":[204],"Collectively,":[206],"these":[207],"findings":[208],"support":[209],"rationale":[211],"for":[212],"determining":[213],"vivo":[216],"activity":[217],"combined":[219],"therapy":[220],"BA":[222,233],"HDI":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2066680949","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":20},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
